173 related articles for article (PubMed ID: 33246951)
1. A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein-2 and zoledronic acid.
Raina DB; Matuszewski LM; Vater C; Bolte J; Isaksson H; Lidgren L; Tägil M; Zwingenberger S
Sci Adv; 2020 Nov; 6(48):. PubMed ID: 33246951
[TBL] [Abstract][Full Text] [Related]
2. Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
Raina DB; Qayoom I; Larsson D; Zheng MH; Kumar A; Isaksson H; Lidgren L; Tägil M
Biomaterials; 2019 Jan; 188():38-49. PubMed ID: 30321863
[TBL] [Abstract][Full Text] [Related]
3. Biomodulation of an implant for enhanced bone-implant anchorage.
Raina DB; Larsson D; Sezgin EA; Isaksson H; Tägil M; Lidgren L
Acta Biomater; 2019 Sep; 96():619-630. PubMed ID: 31301423
[TBL] [Abstract][Full Text] [Related]
4. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
Raina DB; Larsson D; Mrkonjic F; Isaksson H; Kumar A; Lidgren L; Tägil M
J Control Release; 2018 Feb; 272():83-96. PubMed ID: 29329716
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Response to a Bioactive Biphasic Biomaterial in the Femoral Neck of Osteoporotic Rats.
Raina DB; Širka A; Qayoom I; Teotia AK; Liu Y; Tarasevicius S; Tanner KE; Isaksson H; Kumar A; Tägil M; Lidgren L
Tissue Eng Part A; 2020 Oct; 26(19-20):1042-1051. PubMed ID: 32242474
[TBL] [Abstract][Full Text] [Related]
6. Calcium Sulphate/Hydroxyapatite Carrier for Bone Formation in the Femoral Neck of Osteoporotic Rats.
Širka A; Raina DB; Isaksson H; Tanner KE; Smailys A; Kumar A; Tarasevičius Š; Tägil M; Lidgren L
Tissue Eng Part A; 2018 Dec; 24(23-24):1753-1764. PubMed ID: 29855219
[TBL] [Abstract][Full Text] [Related]
7. A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone.
Raina DB; Isaksson H; Hettwer W; Kumar A; Lidgren L; Tägil M
Sci Rep; 2016 May; 6():26033. PubMed ID: 27189411
[TBL] [Abstract][Full Text] [Related]
8. Systemically administered zoledronic acid activates locally implanted synthetic hydroxyapatite particles enhancing peri-implant bone formation: A regenerative medicine approach to improve fracture fixation.
Markeviciute V; Puthia M; Arvidsson L; Liu Y; Törnquist E; Tengattini A; Huang J; Bai Y; Vater C; Petrolis R; Zwingenberger S; Krisciukaitis A; Smailys A; Lukosevicius S; Stravinskas M; Isaksson H; Tarasevicius S; Lidgren L; Tägil M; Raina DB
Acta Biomater; 2024 Apr; 179():354-370. PubMed ID: 38490481
[TBL] [Abstract][Full Text] [Related]
9.
Horstmann PF; Raina DB; Isaksson H; Hettwer W; Lidgren L; Petersen MM; Tägil M
Tissue Eng Part A; 2017 Dec; 23(23-24):1403-1412. PubMed ID: 28537526
[TBL] [Abstract][Full Text] [Related]
10. Sustained delivery of a heterodimer bone morphogenetic protein-2/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing.
Liu Y; Puthia M; Sheehy EJ; Ambite I; Petrlova J; Prithviraj S; Oxborg MW; Sebastian S; Vater C; Zwingenberger S; Struglics A; Bourgine PE; O'Brien FJ; Raina DB
Acta Biomater; 2023 May; 162():164-181. PubMed ID: 36967054
[TBL] [Abstract][Full Text] [Related]
11. Nanohydroxyapatite Based Ceramic Carrier Promotes Bone Formation in a Femoral Neck Canal Defect in Osteoporotic Rats.
Qayoom I; Teotia AK; Kumar A
Biomacromolecules; 2020 Feb; 21(2):328-337. PubMed ID: 31637919
[TBL] [Abstract][Full Text] [Related]
12. Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid.
Deo N; Cheng TL; Mikulec K; Peacock L; Little DG; Schindeler A
J Orthop Res; 2018 Mar; 36(3):930-936. PubMed ID: 28767180
[TBL] [Abstract][Full Text] [Related]
13. The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
Yang JH; Kim HJ; Kim SE; Yun YP; Bae JH; Kim SJ; Choi KH; Song HR
Cytotherapy; 2012 Mar; 14(3):315-26. PubMed ID: 22122301
[TBL] [Abstract][Full Text] [Related]
14. Biocomposite macroporous cryogels as potential carrier scaffolds for bone active agents augmenting bone regeneration.
Raina DB; Isaksson H; Teotia AK; Lidgren L; Tägil M; Kumar A
J Control Release; 2016 Aug; 235():365-378. PubMed ID: 27252151
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model.
Doi Y; Miyazaki M; Yoshiiwa T; Hara K; Kataoka M; Tsumura H
Bone; 2011 Oct; 49(4):777-82. PubMed ID: 21777711
[TBL] [Abstract][Full Text] [Related]
16. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2.
Kim SS; Gwak SJ; Kim BS
J Biomed Mater Res A; 2008 Oct; 87(1):245-53. PubMed ID: 18181112
[TBL] [Abstract][Full Text] [Related]
17. Bone graft substitutes and bone morphogenetic proteins for osteoporotic fractures: what is the evidence?
Van Lieshout EM; Alt V
Injury; 2016 Jan; 47 Suppl 1():S43-6. PubMed ID: 26768291
[TBL] [Abstract][Full Text] [Related]
18. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.
Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE
Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422
[TBL] [Abstract][Full Text] [Related]
19. Nano-Hydroxyapatite Bone Substitute Functionalized with Bone Active Molecules for Enhanced Cranial Bone Regeneration.
Teotia AK; Raina DB; Singh C; Sinha N; Isaksson H; Tägil M; Lidgren L; Kumar A
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6816-6828. PubMed ID: 28171719
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Characterization of a Biocomposite Bone Bandage for Controlled Delivery of Bone-Active Drugs in Fracture Nonunions.
Raina DB; Glencross A; Chaher N; Liu Y; Lidgren L; Isaksson H; Tägil M
ACS Biomater Sci Eng; 2020 May; 6(5):2867-2878. PubMed ID: 33463281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
